Dr. Caroline Apovian: GLP-1 Game Changers | Ep. 06

In this episode of The GLP-1 Podcast Show, I speak with Dr. Caroline Apovian, Professor of Medicine at Harvard Medical School and Co Director of the Center for Weight Management and Wellness at Brigham and Women’s Hospital, about the evolution of obesity treatment. We discuss why obesity is a chronic disease, how GLP-1 based therapies have changed clinical outcomes, and how they compare with lifestyle intervention and metabolic surgery. Dr. Apovian also addresses stigma, access barriers, and the risks of cosmetic use. Listen now on all major platforms!

"Stigma surrounding obesity has forced clinicians to repeatedly prove that treating obesity also prevents cardiovascular disease and diabetes."

Meet the guest: Dr. Caroline Apovian https://www.linkedin.com/in/drapovian/ is Professor of Medicine at Harvard Medical School and Co Director of the Center for Weight Management and Wellness at Brigham and Women’s Hospital. A founding leader in obesity medicine, her research focuses on adipose tissue inflammation, cardiovascular risk, metabolic surgery, and pharmacotherapy for obesity.

To hear Dr. Allison's actual remarks, view the recorded debate here: https://opentodebate.substack.com/p/prescription-weight-loss-drugs-for-all

What you will learn:

(00:00) Highlight

(01:02) Introduction

(04:20) GLP-1 overview

(07:34) Obesity disease model

(13:14) Treatment comparisons

(19:38) Cardiovascular outcomes

(25:23) Cosmetic use debate